Research programme: sensor linked micelle therapeutics - NanoCarrier/TPG Biologics

Drug Profile

Research programme: sensor linked micelle therapeutics - NanoCarrier/TPG Biologics

Latest Information Update: 06 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator NanoCarrier; TPG Biologics
  • Class Antibodies; Drug conjugates; Proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Unspecified

Most Recent Events

  • 05 Apr 2017 NanoCarrier and TPG Biologics enter research collaboration to develop Sensor linked micelle therapeutics
  • 23 Mar 2017 Early research in Undefined indication in Japan (unspecified route)
  • 23 Mar 2017 Early research in Undefined indication in Taiwan (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top